LGD-4033 (Ligandrol) Capsules

€ 54,95

LGD-4033 capsules, also identified as Ligandrol, contain a formulated presentation of a non-steroidal androgen-receptor research compound offered by Raw Lab Chems with seller-specified ≥98% purity. The material is intended exclusively for controlled in-vitro, chemical, forensic, and analytical research.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13108 Category:
Description

LGD-4033 (Ligandrol) Capsules

Product Overview

LGD-4033 capsules, also identified as Ligandrol capsules, provide a formulated presentation of LGD-4033, a synthetic research compound described in the supplied information as a non-steroidal selective androgen receptor modulator (SARM). The material is positioned for controlled analytical, structural, chromatographic, forensic, and comparative laboratory investigation.

Raw Lab Chems presents this material exclusively for laboratory and analytical research. The supplied specification states ≥98% purity for a typical batch. Although the source describes this value as third-party verified, no corresponding Certificate of Analysis or independent laboratory report accompanied the supplied information. The purity value is therefore treated as seller-provided information rather than independently verified analytical evidence.

The supplied material discusses receptor-binding interactions, tissue-selective androgen-receptor research, structure-activity relationships, analytical detection, and biochemical assays. These subjects establish scientific research context only and are not presented as therapeutic, hormonal, muscle-building, athletic-performance, or other personal-use benefits.

Chemical Identity & Classification

The supplied systematic chemical name is 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile.

The source provides CAS 1165910-22-4, molecular formula C14H12F6N2O, and molecular weight 338.25 g/mol. It identifies the material as LGD-4033, also known as Ligandrol, and describes it as belonging to the arylpropionamide class of selective androgen receptor modulators.

The supplied systematic name contains defined (2R) and (1R) stereochemical designations. These identifiers should be preserved in identity-sensitive laboratory records rather than assuming that unspecified stereochemical forms are chemically or analytically equivalent.

The supplied chemical name, CAS number, molecular formula, and molecular weight are reproduced as provided. They have not been silently corrected or reconciled against external chemical databases.

Researchers may consult PubChem for public chemical-reference information. Any selected database record should be checked against the exact identity, stereochemistry, and chemical form documented for the research sample.

Chemical & Physical Characteristics

The material is described as a capsule formulation intended for controlled laboratory handling and analytical investigation. No verified capsule color, shell composition, dimensions, fill appearance, excipient profile, particle-size distribution, or other formulation-specific physical characteristics were supplied.

The molecular formula C14H12F6N2O and molecular weight 338.25 g/mol describe the underlying LGD-4033 compound according to the supplied source rather than the complete capsule formulation. Capsule-shell materials and any unspecified excipients would constitute additional components and should be considered separately during formulation-specific analysis.

No quantitative solubility data, melting point, density, hygroscopicity, or other detailed physicochemical measurements were supplied in this capsule-specific source. These characteristics are therefore not inferred from powder presentations or other SARM-class research materials.

The source recommends storage in a cool, dry environment protected from light and identifies 2–8°C as the preferred range for optimal long-term stability. No supporting stability study, degradation profile, validated shelf-life dataset, or temperature-excursion study accompanied the source. This recommendation is therefore retained as seller-provided storage guidance rather than independently validated stability data.

Purity & Analytical Verification

The supplied specification for LGD-4033 capsules states ≥98% purity for a typical batch of the underlying research compound.

The source characterizes this specification as third-party verified and states that a third-party Certificate of Analysis is available upon request. HPLC, LC-MS, and NMR spectroscopy are additionally identified as analytical techniques relevant to characterization of the material.

No batch-specific Certificate of Analysis, HPLC chromatogram, LC-MS dataset, NMR spectrum, or independent laboratory report accompanied the supplied information. Consequently, the stated purity and third-party verification claims are treated as seller-supplied information rather than independently established analytical results for a particular batch.

HPLC, LC-MS, NMR, and related instrumental methods can support laboratory characterization when appropriately validated for the intended analytical objective. Depending on methodology, these techniques may provide information concerning chemical identity, purity, impurity profiles, structural characteristics, and differentiation from related research compounds.

Because this is a formulated research material, chemical purity and formulation uniformity represent separate analytical characteristics. A stated purity specification for the underlying compound does not independently establish the composition or uniform distribution of the complete capsule formulation.

Quality Control & Batch Integrity

Reliable analytical research requires documentation connecting experimental observations to the exact material examined. Useful laboratory records can include chemical identity, stereochemical designation, formulation type, supplier, lot or batch identifier, receipt date, storage history, analytical documentation, and chain-of-custody information where appropriate.

The supplied source describes batch-specific tracking, full documentation for traceability, independent laboratory verification of identity and purity, third-party Certificate of Analysis availability, and production under ISO-compliant conditions.

No supporting ISO certification, quality-system documentation, Certificate of Analysis, batch record, independent laboratory report, formulation-uniformity study, or other underlying quality documentation was supplied. These statements therefore remain source-provided quality claims rather than independently established certifications or guarantees.

Researchers conducting comparative, forensic, or longitudinal analytical studies should ensure that observations can be connected to the precise research sample examined. Differences in lots, formulations, storage histories, reference standards, or analytical methods may introduce variables relevant to interpretation.

No additional third-party certification, manufacturing-standard, or lot-to-lot reproducibility guarantee is made without supporting documentation.

Safety, Handling & Laboratory Precautions

LGD-4033 should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, ventilation, containment, access restrictions, and waste-management procedures should be established through institutional risk assessment and applicable safety documentation.

The compound’s experimental association with androgen-receptor research should be considered when laboratories establish appropriate controls. Activity observed in biochemical or cellular experimental systems does not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet for the exact compound and formulation when establishing procedures concerning accidental exposure, spills, contamination control, environmental release, waste collection, and disposal.

The material should remain secured against unauthorized access and separated from food, beverages, children, pets, and non-research environments. Laboratory procedures should also minimize unintended contamination of analytical instruments, samples, work surfaces, and waste streams.

Packaging, Labeling & Storage

The supplied source states that orders are securely packaged with labeling appropriate for chemical research materials. No packaging specification, container-closure validation, transportation study, or supporting technical documentation was provided to independently establish these characteristics.

The supplied storage recommendation specifies a cool, dry environment protected from light, with 2–8°C identified as the preferred range for long-term stability. This recommendation is retained as source-provided guidance rather than represented as independently validated Raw Lab Chems stability data.

Researchers should follow documentation applicable to the specific batch, relevant SDS guidance, and institutional chemical-storage requirements.

Because the material is supplied as a capsule formulation, laboratory records should distinguish the complete formulation from isolated LGD-4033 reference material. Labels should preserve the LGD-4033 and Ligandrol identifiers, relevant stereochemical information, and lot or batch identifier where available. Storage history should also be documented when environmental variables could influence subsequent analytical observations.

Intended Research Use & Market Positioning

LGD-4033 is positioned for controlled laboratory investigation involving chemical characterization, analytical reference work, androgen-receptor research, comparative SARM chemistry, structure-activity relationships, chromatographic detection, forensic analysis, and analytical method development.

The supplied source specifically identifies HPLC, LC-MS, and NMR spectroscopy as relevant analytical techniques. It also describes detection in complex matrices, pharmaceutical impurity profiling, and academic investigation of selective androgen receptor modulator analogues as potential research contexts.

References to androgen-receptor binding and tissue selectivity describe subjects of experimental investigation rather than established medical, physiological, muscle-building, or performance benefits.

Researchers comparing different presentations of the same named compound can separately review Raw Lab Chems LGD-4033 Powder (Ligandrol). Powder and capsule formulations should not automatically be treated as analytically interchangeable because formulation components may differ.

For comparative catalog research involving another SARM-class material, Raw Lab Chems also lists RAD-150 Capsules.

The Raw Lab Chems LGD-4033 Ligandrol Capsules research listing provides the supplied catalog reference for the formulation described here.

No medical, therapeutic, diagnostic, veterinary, hormonal, bodybuilding, muscle-building, athletic-performance, or consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement of LGD-4033 should begin with confirmation of the required chemical identity, stereochemical specification, formulation, analytical documentation, institutional authorization, and jurisdiction-specific requirements applicable to the proposed research.

The supplied source describes worldwide shipping to qualified research institutions, secure packaging, chemical-research labeling, and shipment tracking. These logistics statements are not independently verified here, and no current fulfillment documentation was supplied.

No claims are therefore made concerning current inventory, package configurations, dispatch schedules, delivery times, shipping destinations, courier services, tracking availability, customs processing, geographic availability, or payment methods.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of this material are permitted and appropriately authorized within their jurisdiction and institutional framework.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

LGD-4033 is presented as an experimental laboratory research compound. Regulatory treatment may differ according to jurisdiction, intended research activity, institutional policy, and applicable medicines, sporting, chemical-control, forensic, or research frameworks.

Researchers and institutions are responsible for determining and complying with applicable requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from anti-doping, medicines, chemical-control, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “LGD-4033 (Ligandrol) Capsules”
Shipping & Delivery